Thalidomide-O-amido-PEG2-C2-NH2 (TFA)

≥99%

  • Product Code: 102908
  CAS:    1957235-75-4
Molecular Weight: 576.48 g./mol Molecular Formula: C₂₃H₂₇F₃N₄O₁₀
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: 2-8℃
Product Description: This compound is primarily utilized in the development of targeted cancer therapies. It functions as a linker in antibody-drug conjugates (ADCs), enabling the precise delivery of cytotoxic agents to cancer cells while minimizing damage to healthy tissues. The inclusion of thalidomide allows for additional modulation of protein degradation, particularly in targeting specific proteins involved in cancer progression. Its PEG2 spacer enhances solubility and stability, improving the pharmacokinetic properties of the conjugate. This makes it a valuable tool in advancing personalized medicine and improving the efficacy of cancer treatments.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.100 10-20 days £902.42
+
-
0.500 10-20 days £3,663.95
+
-
Thalidomide-O-amido-PEG2-C2-NH2 (TFA)
This compound is primarily utilized in the development of targeted cancer therapies. It functions as a linker in antibody-drug conjugates (ADCs), enabling the precise delivery of cytotoxic agents to cancer cells while minimizing damage to healthy tissues. The inclusion of thalidomide allows for additional modulation of protein degradation, particularly in targeting specific proteins involved in cancer progression. Its PEG2 spacer enhances solubility and stability, improving the pharmacokinetic properties of the conjugate. This makes it a valuable tool in advancing personalized medicine and improving the efficacy of cancer treatments.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: £0.00
£0.00 Total :